Learning health systems

Discovery Behavioral Health Launches First-of-its-kind AI Platform with Videra Health and Leading Research Hospital to Address the "One Year Recovery Gap"

Retrieved on: 
Thursday, September 28, 2023
Depressive anxiety, Learning, Depression, Learning health systems, Eating disorder, Harvard T.H. Chan School of Public Health, Social, Smartphone, Cone Health Women's Hospital, Speech, Brigham and Women's Hospital, Data collection, Social determinants of health, DBH, Practice, Doctor of Philosophy, Language, Harvard University, Behavior, Harvard Medical School, Medicine, Discovery, Public health, MD, Patient, Eating, Psychiatry, Hospital, LOS, Medical imaging, Pharmaceutical industry, Medical device, Nursing, Brigham

LOS ANGELES, Sept. 28, 2023 /PRNewswire/ -- Discovery Behavioral Health, Inc., an expanding network of 165 evidence-based mental health, substance use and eating disorder treatment centers, has entered into a clinical research agreement that will play an integral role in the launch of a new A.I.-driven platform called Discovery365. The platform tracks patient progress for 12 months after discharge from a behavioral treatment program, a period Discovery refers to as "the one-year recovery gap," when industry relapse rates are exceedingly high. The agreement joins Discovery Behavioral Health with experts from Brigham and Women's Hospital. Powered by Videra Health technology, the Discovery365 platform represents a paradigm shift in the industry.

Key Points: 
  • The agreement joins Discovery Behavioral Health with experts from Brigham and Women's Hospital .
  • Powered by Videra Health technology, the Discovery365 platform represents a paradigm shift in the industry.
  • We are working to make relapse the exception, not the rule of recovery," says John Peloquin, PhD, President and CEO of Discovery Behavioral Health.
  • "Infusing AI into the world of behavioral health through this trailblazing platform will significantly advance solutions for the betterment of patients everywhere.

Upperline Health Expands Executive Leadership Team to Scale Specialty Value-Based Care Across the United States

Retrieved on: 
Wednesday, September 20, 2023
Managed Care, General Health, Health, Other Health, New York University Stern School of Business, Walgreens Boots Alliance, Nordstrom, University, Risk-adjusted return on capital, Internal medicine, Hospital, Harvard University, McKesson Corporation, Business, Bed, Lindy, MBA, McKinsey & Company, Harvard Medical School, Medicare, Wharton School of the University of Pennsylvania, Development, Talent, Medical director, Accounting, Patient, Population health, Acqui-hiring, Conditional sentence, Widener University Commonwealth Law School, Healthcare in the United States, Harvard Business School, Oak Street Health, Optum, Growth, Learning health systems, Management, Nursing, Finance

This new cohort of top industry talent will join Upperline Health’s Nashville headquarters and help lead efforts to scale the business and expand Upperline Plus , its value-based care program.

Key Points: 
  • This new cohort of top industry talent will join Upperline Health’s Nashville headquarters and help lead efforts to scale the business and expand Upperline Plus , its value-based care program.
  • Previously, he held senior finance, business development and operations positions with value-based care provider agilon health and global healthcare organization, McKesson.
  • She brings extensive value-based care experience to the company, joining from Oak Street Health where she served as Medical Director of Population Health.
  • Through its specialty value-based care model, Upperline Health is helping more patients better manage chronic illness and transform their lifestyles via preventative care.

Sinopia Awarded Grant from National Institute of Dental and Craniofacial Research for Oral Mucositis

Retrieved on: 
Thursday, February 23, 2023
Technology, Biotechnology, FDA, Health, Radiology, Oncology, Other Science, Research, Software, General Health, Health Technology, Science, Data Management, Clinical Trials, Discover, Overalls, National Institute of Dental and Craniofacial Research, Prognosis, Patient, Inflammation, Learning health systems, Therapy, Ulcer, Machine learning, Head, Bangladesh Technical Education Board, Radiation, NIDCR, Pharmaceutical industry, Dentistry, Mucositis

Sinopia Biosciences, Inc. , a biotechnology company advancing novel therapeutics identified using its proprietary computational drug discovery platform, has been awarded a grant from the National Institute of Dental and Craniofacial Research (NIDCR), a branch of the U.S. National Institutes of Health, to fund the continued evaluation of therapeutic candidates to treat oral mucositis.

Key Points: 
  • Sinopia Biosciences, Inc. , a biotechnology company advancing novel therapeutics identified using its proprietary computational drug discovery platform, has been awarded a grant from the National Institute of Dental and Craniofacial Research (NIDCR), a branch of the U.S. National Institutes of Health, to fund the continued evaluation of therapeutic candidates to treat oral mucositis.
  • Mucositis is a debilitating side effect of chemotherapy and radiotherapy that is characterized by inflammation and ulceration in mucosal tissue.
  • “When mucositis presents itself in cancer clinical care, there can be a delay in antineoplastic treatment for high-grade mucositis management that can lead to worse overall prognosis and significantly higher healthcare costs.
  • The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Dr. Blackford Middleton Joins ClosedLoop to Improve Clinical Decisions With AI

Retrieved on: 
Thursday, January 27, 2022
Knowledge, Vanderbilt University, Health, AHRQ, CEO, Quadruple, Fellow, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, CMS, Stanford University, Health policy, Explainable artificial intelligence, Public health, Blackford, Expert, Machine learning, Health information management, Data science, Assistant, Informatics, PHR, ACTS, Learning health systems, Vanderbilt, Cone Health Women's Hospital, Mass, Journal, CIO, Harvard Medical School, Hospital, Editorial board, D, Agency for Healthcare Research and Quality, Health informatics, Mass General Brigham, EHR, Laika (EHR testing framework), Innovation, GLOBE, Population health, Medical device, Medicine, Management, Medicine, Brigham, AI

AUSTIN, Texas, Jan. 27, 2022 (GLOBE NEWSWIRE) -- ClosedLoop , healthcare's data science platform, today announced that renowned clinical informatics expert Dr. Blackford Middleton has joined ClosedLoop as Chief Medical Officer.

Key Points: 
  • AUSTIN, Texas, Jan. 27, 2022 (GLOBE NEWSWIRE) -- ClosedLoop , healthcare's data science platform, today announced that renowned clinical informatics expert Dr. Blackford Middleton has joined ClosedLoop as Chief Medical Officer.
  • At ClosedLoop, Dr. Middleton will help identify relevant informatics standards, support clinical content development and use, and assist in company strategy, product design, and customer success.
  • "ClosedLoop is the leader in predictive AI for healthcarewinning the CMS AI Health Outcomes Challenge is testament to that," said Dr. Middleton.
  • Winner of the CMS AI Health Outcomes Challenge and named a KLAS Healthcare AI Top Performer for 2020, ClosedLoop is headquartered in Austin, Texas.

Statement from the Minister of Mental Health and Addictions on the Overdose Crisis

Retrieved on: 
Wednesday, December 15, 2021
Solution, MTI College, Government, Center, Indigenous peoples, Heart, Centre for Addiction and Mental Health, Population, Substance, Friends, Mental health, Addiction, Trauma, Income, Australian National Task Force on Cannabis, COVID-19, Task force, Risk, Chronic pain, Housing, Man, Learning health systems, Hearing, Data collection, Substance-related disorder, First Nations, Health, Pharmaceutical industry, Medicine

The recent national data and modelling projections on opioid overdose deaths confirms the negative effect COVID-19 has had on the overdose crisis.

Key Points: 
  • The recent national data and modelling projections on opioid overdose deaths confirms the negative effect COVID-19 has had on the overdose crisis.
  • As mental health and substance use among Canadians have worsened during the pandemic, it is clear that solutions to the overdose crisis must consider broader health and social issues.
  • As the Centre for Addiction and Mental Health reminds us every day: mental health is health.
  • Our government has committed over $700 million since 2017 to address the opioid overdose crisis.

Health Research Foundation Announces Recipient of Its New Fellowship in Health Systems Resilience

Retrieved on: 
Thursday, October 28, 2021
Health, Research, Thunder Bay Regional Health Sciences Centre, SCAN Health Plan, Industry, Public policy, Foundation, Pandemic, COVID-19, Faculty of Medicine, University of Malaya, Fellow, Learning health systems, HRF, Education, Medical device, Medicine

Ottawa, Ontario--(Newsfile Corp. - October 28, 2021) - The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Brianne Wood has been awarded the Fellowship in Health Systems Resilience.

Key Points: 
  • Ottawa, Ontario--(Newsfile Corp. - October 28, 2021) - The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Brianne Wood has been awarded the Fellowship in Health Systems Resilience.
  • She will investigate how these communities and their health systems can better generate knowledge for decision- and policy-making during public health emergencies and ongoing health systems transformation.
  • This Fellowship will enable me to better prepare underserved health systems to meet the needs of their health workforce and the communities they serve," Dr. Brianne Wood.
  • "The Fellowship in Health Systems Resilience is a vital piece in HRF's research strategy as we form deeper partnerships and prepare for future health challenges.

Clarify Health Acquires Apervita’s Value Optimization Business, Creating One Unified Value Platform for Health Plans

Retrieved on: 
Wednesday, August 4, 2021
Data Management, Practice Management, Technology, Professional Services, Other Health, Health, General Health, Software, Hospitals, Insurance, Finance, Articles, Business intelligence, Formal sciences, Analytics, Big data, Clarify Health, Apervita, CLARIFY HEALTH, APERVITA

A trusted platform that can objectively and transparently analyze data from plans and providers is a foundational enabler to the success of new payment models.

Key Points: 
  • A trusted platform that can objectively and transparently analyze data from plans and providers is a foundational enabler to the success of new payment models.
  • The acquisition of Apervitas Value Optimization business comes on the heels of Clarify Healths $115M Series C funding led by Insight Partners.
  • "We are delighted by the synergy between Apervitas Value Optimization Solution and Clarifys analytics platform, which will unleash a ground-breaking end-to-end solution," said Kevin Hutchinson, CEO of Apervita.
  • Clarify Health is a technology company whose enterprise analytics cloud transforms healthcare data into actionable insights for providers, health plans, and life sciences companies.